Back to top

Image: Bigstock

Will RedHill Biopharma Continue to Surge Higher?

Read MoreHide Full Article

As of late, it has definitely been a great time to be an investor RedHill Biopharma Ltd. (RDHL - Free Report) .The stock has moved higher by 36.7% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider RDHL’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as RDHL has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.  

See the pot trades we're targeting>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Redhill Biopharma Ltd. (RDHL) - free report >>

Published in